Fibroblasts and IPSC's
The foundation contracted with Coriell to create iPSC Lines that are currently available for distribution via Wicell
Upitt is in the process of creating a Rosa26 Knock-in conditional mouse model, as well as a Conditional mouse-model. To be available Early 2020.
CRISPR Knock-in cell-line
Systems Biosciences has contracted with the PACS1 Syndrome Research Foundation and has created CRISPR knock-in HELA cell lines that are available.